These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8355073)

  • 1. Measurement of myocardial blood flow by radiolabeled tracers.
    Wilson RA
    J Nucl Med; 1993 Sep; 34(9):1518-9. PubMed ID: 8355073
    [No Abstract]   [Full Text] [Related]  

  • 2. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 3. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 5. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of myocardial viability by isotopic methods].
    Latre Romero JM; Vallés Belsué F
    Rev Esp Cardiol; 1994; 47 Suppl 4():116-23. PubMed ID: 7863076
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thallium-201 and sestamibi: principles and kinetics of the two tracers].
    Parodi O
    G Ital Cardiol; 1991 Aug; 21(8):885-8. PubMed ID: 1837528
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.
    Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O
    J Nucl Biol Med (1991); 1994 Dec; 38(4):566-72. PubMed ID: 7786918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST; Leppo JA
    Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of cardiac imaging with sestamibi and teboroxime.
    Leppo JA; DePuey EG; Johnson LL
    J Nucl Med; 1991 Oct; 32(10):2012-22. PubMed ID: 1833519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
    Li QS; Solot G; Frank TL; Wagner HN; Becker LC
    J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer technetium-99m--labeled myocardial perfusion imaging agents: clinical indications.
    Bisson G; Hendel RC; Taillefer R
    Am J Card Imaging; 1994 Jul; 8(3):213-22. PubMed ID: 7950172
    [No Abstract]   [Full Text] [Related]  

  • 17. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is redistribution important in sestamibi myocardial imaging?
    Iskandrian AS
    J Nucl Med; 1991 Oct; 32(10):1966-7. PubMed ID: 1833518
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial perfusion imaging has grown dramatically.
    Berman DS
    Semin Nucl Med; 1991 Jul; 21(3):170-2. PubMed ID: 1835135
    [No Abstract]   [Full Text] [Related]  

  • 20. Perfusion scintigraphy and evaluation of myocardial viability.
    McKillop JH
    Nucl Med Commun; 1991 Aug; 12(8):659-62. PubMed ID: 1780107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.